本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

149.50
-0.5200-0.35%
盤後149.42-0.0800-0.05%16:52 EDT
成交量:101.54萬
成交額:1.52億
市值:152.49億
市盈率:21.91
高:151.31
開:150.34
低:149.00
收:150.02
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.02
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.13
市盈率(LYR):32.01

資料載入中...

2023/10/05

重要事件披露

Form 8-K - Current report
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

重要事件披露

Form 8-K - Current report
2023/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

重要事件披露

Form 8-K - Current report